Any way to get some additional information on the protocols being used? What about the suppression of hpta by hcg - in the presentation he had people recovering pretty fast after stopping and if I understood correctly settle at higher levels of natural T?
It always puzzled me how and why he ended up using 5000iu, and no less than twice per week, the most sensible scenario is that pregnyl etc come in that and are labeled single use.4. The treatment of late-onset hypogonadism
4.1 Late-onset hypogonadism and hCG therapy
The effect of the treatment of 908 patients taking hCG was described in 2010 (Gomula & Rabijewski, 2010). Below, I present a further study of 1200 men (age range 20-89 years; mean, 54). The mean follow-up period of the patients was over 37 months. During the therapy with hCG (2 x 5000 i.u. per week), there was an average increase in serum concentrations of total testosterone from 18.4 nmol/L to 38.59 nmol/L. It was noted that during the hCG therapy, there was no increase in SHBG. On the contrary, the SHBG concentrations even showed a slight decrease. This meant that as the result of hCG treatment, free and bioavailable testosterone concentrations increased. The rise was proportional to that in total testosterone, as was reported (Fiers & Kaufman, 1999). There was an average increase in free testosterone concentrations from 0.0829 ng/mL (1.98%) to 0.201 ng/mL (2.29%) The bio-available testosterone concentration also increased: − on average from 1.94 ng/mL (46.4%) to 4.71 ng /mL (53.6%). At the same time, there was a steady increase in the average concentration of estradiol, from 138.6 pmol/L to 280.9 pmol/L. In parallel, the average PSA level decreased by 40% (from 3.09 ng/mL to 1.83 ng/mL) after 37 months of therapy. These results are shown in Table 9, below.